BRC Stock Analysis: Brady | NYSE
Security & Protection Services | NYSE, USA | Market Cap: 4.346m USD | 12M Return: 31.3% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 26.4M
EPS Trend: 98.5%
Qual. Beats: 1
Rev. Trend: 95.9%
Qual. Beats: 1
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Brady Corporation is a global manufacturer of identification solutions and workplace safety products, serving customers across the Americas, Asia, Europe, and Australia. Its product portfolio spans safety and traffic signs, floor-marking tapes, pipe markers, lockout/tagout devices, spill control, personal protection equipment, and first aid supplies, along with labeling systems, RFID and barcode scanners, engraving equipment, and asset tracking tags for industrial applications. The company also supplies healthcare-oriented products such as patient wristbands and labels, as well as ID badging, lanyards, and access control systems.
Brady serves a highly diversified end-market base, including industrial and electronic manufacturing, healthcare, chemical, oil and gas, alternative energy, automotive, aerospace, government, mass transit, construction, utilities, education, retail, and telecommunications. The company distributes through multiple channels-a network of distributors, a direct sales force, and digital/e-commerce platforms. Brady was incorporated in 1914 and is headquartered in Milwaukee, Wisconsin.
Within the broader market classification, Brady is categorized under the Industrials sector and the Commercial Printing sub-industry (GICS), reflecting the labeling and printed identification nature of much of its core product line. Its business model combines physical product manufacturing with recurring software and service offerings for safety compliance auditing, procedure writing, and training, which support customer retention across regulated industries.
- Industrial manufacturing cycle drives identification product demand
- Pricing actions and productivity lift operating margins
- Acquisitions expand identification and traceability portfolio
| Net Income: 209.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA -0.55 > 1.0 |
| NWC/Revenue: 21.03% < 20% (prev 18.50%; Δ 2.53% < -1%) |
| CFO/TA 0.12 > 3% & CFO 223.2m > Net Income 209.7m |
| Net Debt (-25.3m) to EBITDA (312.9m): -0.08 < 3 |
| Current Ratio: 2.01 > 1.5 & < 3 |
| Outstanding Shares: last quarter (47.8m) vs 12m ago -0.52% < -2% |
| Gross Margin: 51.11% > 18% (prev 50.53%; Δ 0.57% > 0.5%) |
| Asset Turnover: 91.89% > 50% (prev 85.96%; Δ 5.93% > 0%) |
| Interest Coverage Ratio: 58.34 > 6 (EBIT TTM 269.0m / Interest Expense TTM 4.61m) |
| A: 0.19 (Total Current Assets 678.9m - Total Current Liabilities 337.8m) / Total Assets 1.83b |
| B: 0.79 (Retained Earnings 1.44b / Total Assets 1.83b) |
| C: 0.15 (EBIT TTM 269.0m / Avg Total Assets 1.77b) |
| D: 2.75 (Book Value of Equity 1.34b / Total Liabilities 488.0m) |
| Altman-Z'' = 7.71 = AAA |
| DSRI: 1.07 (Receivables 266.4m/224.4m, Revenue 1.62b/1.46b) |
| GMI: 0.99 (GM 50.53% / 51.11%) |
| AQI: 0.94 (AQ_t 0.46 / AQ_t-1 0.49) |
| SGI: 1.11 (Revenue 1.62b / 1.46b) |
| TATA: -0.01 (NI 209.7m - CFO 223.2m) / TA 1.83b) |
| Beneish M = -2.94 (Cap -4..+1) = A |
As of July 11, 2026, the stock is trading at USD 90.16 with a total of 112,608 shares traded. Over the past week, the price has changed by -1.67%, over one month by +16.10%, over three months by +7.92% and over the past year by +31.30%.
Current recommended Stop Loss: 86.60 (which is 3.9% or 1.3 ATR below the current price).
Brady has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy BRC.
- StrongBuy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 101.5 | 12.6% |
P/E Trailing = 20.9659
P/E Forward = 15.361
P/S = 2.6796
P/B = 3.2229
P/EG = 1.6733
Revenue TTM = 1.62b USD
EBIT TTM = 269.0m USD
EBITDA TTM = 312.9m USD
Long Term Debt = 26.9m USD (from longTermDebt, last quarter)
Short Term Debt = 16.4m USD (from shortTermDebt, last quarter)
Debt = 150.2m USD (from shortLongTermDebtTotal, last quarter) + Leases 61.7m
Net Debt = -25.3m USD (calculated: Debt 150.2m - CCE 175.5m)
Enterprise Value = 4.32b USD (4.35b + Debt 150.2m - CCE 175.5m)
Interest Coverage Ratio = 58.34 (Ebit TTM 269.0m / Interest Expense TTM 4.61m)
EV/FCF = 23.83x (Enterprise Value 4.32b / FCF TTM 181.3m)
FCF Yield = 4.20% (FCF TTM 181.3m / Enterprise Value 4.32b)
FCF Margin = 11.18% (FCF TTM 181.3m / Revenue TTM 1.62b)
Net Margin = 12.93% (Net Income TTM 209.7m / Revenue TTM 1.62b)
Gross Margin = 51.11% ((Revenue TTM 1.62b - Cost of Revenue TTM 793.0m) / Revenue TTM)
Gross Margin QoQ = 51.80% (prev 50.61%)
Tobins Q-Ratio = 2.36 (Enterprise Value 4.32b / Total Assets 1.83b)
Interest Expense / Debt = 3.07% (Interest Expense 4.61m / Debt 150.2m)
Taxrate = 20.69% (54.7m / 264.4m)
NOPAT = 213.3m (EBIT 269.0m * (1 - 20.69%))
Current Ratio = 2.01 (Total Current Assets 678.9m / Total Current Liabilities 337.8m)
Debt / Equity = 0.11 (Debt 150.2m / totalStockholderEquity, last quarter 1.34b)
Debt / EBITDA = -0.08 (Net Debt -25.3m / EBITDA 312.9m)
Debt / FCF = -0.14 (Net Debt -25.3m / FCF TTM 181.3m)
Total Stockholder Equity = 1.27b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.88% (Net Income 209.7m / Total Assets 1.83b)
RoE = 16.46% (Net Income TTM 209.7m / Total Stockholder Equity 1.27b)
RoCE = 20.68% (EBIT 269.0m / Capital Employed (Equity 1.27b + L.T.Debt 26.9m))
RoIC = 14.92% (NOPAT 213.3m / Invested Capital 1.43b)
WACC = 8.37% (E(4.35b)/V(4.50b) * Re(8.58%) + D(150.2m)/V(4.50b) * Rd(3.07%) * (1-Tc(0.21)))
Discount Rate = 8.58% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -64.44 | Cagr: -0.84%
[DCF] Terminal Value 75.64% ; FCFF base≈179.8m ; Y1≈183.8m ; Y5≈201.9m
[DCF] Fair Price = 72.07 (EV 3.12b - Net Debt -25.3m = Equity 3.14b / Shares 43.6m; r=8.37% [WACC]; 5y FCF grow 2.20% → 2.50% )
EPS Correlation: 98.50 | EPS CAGR: 10.84% | SUE: 4.0 | # QB: 1
Revenue Correlation: 95.92 | Revenue CAGR: 7.92% | SUE: 3.92 | # QB: 1
EPS current Quarter (2026-10-31): EPS=1.30 | Chg30d=+0.78% | Revisions=+0% | Analysts=2
EPS current Year (2026-07-31): EPS=5.28 | Chg30d=+4.87% | Revisions=+40% | GrowthEPS=+14.7% | GrowthRev=+9.2%
EPS next Year (2027-07-31): EPS=6.09 | Chg30d=+5.18% | Revisions=+40% | GrowthEPS=+15.4% | GrowthRev=+53.1%
[Analyst] Revisions Ratio: +44% (up=5, down=1)